Axcella Health Inc AXLA - En Passiv Inkomst
Axla Wellness Ystad Priser - Canal Midi
2021-04-06 · Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. At Axcella, we are seeking to unlock the full potential of EMMs by combining a deep understanding of biological pathways with recent advances in systems biology and machine learning. The end result: Multi-targeted EMM compositions with the potential to have profound impacts on complex diseases and support health. Axcella Health (AXLA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
The reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.36) by $0.04. Axcella Health has generated ($3.55) earnings per share over the last year. Find the latest Axcella Health Inc. (AXLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 2021-04-13 · Axcella Health Inc. Common Stock (AXLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2020-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $4.75 per share, before deducting underwriting discounts and commissions.
Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Axcella Health reaches your desired price. The Investor Relations website contains information about Axcella Health Inc.'s business for stockholders, potential investors, and financial analysts.
Aktiekurser för samtliga börslistor - Dagens Industri
The Company focuses on research and development of multifactorial interventions to support health and address dysregulated metabolism across a spectrum of consumers. It designs and develops endogenous metabolic modulators. 2020-08-02 · View the latest Axcella Health Inc. (AXLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Many investors turn to CNBC stock market live for daily updates on the companies they're watching. Read on for 15 things to know about the U.S. stock market.
Axcella to Report Fourth Quarter and Full Year 2020 Financial
Get the latest Axcella Health Inc (AXLA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Today, we revisit Axcella Health for the first time in a year.
8000 Stocks See the list of fundamentally undervalued stocks that should be in your portfolio.
Isf förkortning engelska
Get the latest Axcella Health Inc. (AXLA) stock news and headlines to help you in your trading and investing decisions. Original Value. Current Shares. Current Value.
See today’s analyst top recommended stocks >>
Axcella Health (AXLA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes. Axcella Health (AXLA) Jumps: Stock Rises 5.9% - July 1, 2020 - Zacks.com
Axcella Health Inc. (NASDAQ: AXLA) stock closed at 4.34 per share at the end of the most recent trading day (a -5.24 % change compared to the prior day closing price) with a volume of 77.89K shares and market capitalization of 163.57M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 66 people.
Personlighetstest färger disc analys
umberto riva
jens ganman årets svensk
vinterdekk av
hur mycket f skatt ska man betala i enskild firma
empatisk förmåga test
Grafiek Axcella Health Inc - Scanaktier.se
Share your opinion and gain insight from other stock traders and investors. 2021-04-13 · Axcella Health Inc. Common Stock (AXLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2020-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $4.75 per share, before deducting underwriting discounts and commissions. Axcella Health Inc. (AXLA) Add to watchlist.
Grafiek Axcella Health Inc - Scanaktier.se
Denna sida innehåller de senaste nyheterna om Axcella Health Inc aktien. Få detaljerad information om Axcella Health Inc (AXLA) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Axcella Health rapporter och mycket mer. Noteringar.
2021-03-17 · Axcella Health's stock was trading at $3.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization.